During an AHA press conference, Li explained that each component of the triple-receptor agonist compensates for side effects ...

Other risk factors for kidney disease include chronic infections, autoimmune disorders, and certain genetic variants. The new ...

NEW ORLEANS -- Innovations in lipid lowering get a major chance to shine, and potentially move the needle in cardiometabolic ...

In a small, short-term, Phase 2 clinical trial in adults, a first-of-its-kind medication reduced triglyceride levels in most ...

Students at Sunset Mesa Elementary raised more than $30,000 for the American Heart Association. For the fifth year in a row, ...

One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...

If someone went into cardiac arrest in front of you, would you know how to save them? That’s a question a local girl and the ...

A single infusion of CRISPR Therapeutics' experimental gene therapy was safe and reduced levels of harmful LDL cholesterol and triglycerides by half in four people taking the highest dose, raising ...

The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...

New research has raised concerns about the long-term use of melatonin supplements, which are widely available for purchase in ...

Long-term use of melatonin supplements for sleep may be linked to a greater risk for heart failure, a recent study suggests.

A preliminary study suggests melatonin may pose risks to heart health. The American Heart Association reported.